Legal status · Australia
Is Lanreotide legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Lanreotide is an approved medicine in Australia, classified as "TGA-registered, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Lanreotide in Australia at a glance
| Classification | TGA-registered, prescription only |
|---|---|
| TGA approval status | Approved by TGA for its labeled use |
| Human studies cited | 1 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Lanreotide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
TGA has approved Lanreotide for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Lanreotide is
A somatostatin analogue that extended progression-free survival in neuroendocrine tumours in a randomised phase 3, which is a hard endpoint that very few peptides on this site can claim.
Somatostatin is the body's universal inhibitory hormone, switching off growth hormone, insulin, glucagon and most gut secretions. Its native half-life is a couple of minutes, so the useful drugs are engineered analogues, and lanreotide is one of two that matter clinically alongside octreotide.
Mechanism: A cyclic octapeptide analogue of somatostatin with high affinity for somatostatin receptor subtypes 2 and 5, formulated as a prolonged-release depot. Activating those receptors, which are G protein-coupled and inhibitory, suppresses hormone secretion from pituitary and neuroendocrine cells and reduces gut motility and secretion.
Regulatory history: FDA-approved for acromegaly, for gastroenteropancreatic neuroendocrine tumours to improve progression-free survival, and for carcinoid syndrome.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Lanreotide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Lanreotide in other countries
Frequently asked questions
Is Lanreotide legal in Australia?
Yes. Lanreotide is an approved medicine in Australia, classified as "TGA-registered, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Can I buy Lanreotide in Australia?
Only with a prescription. Lanreotide is classified as "TGA-registered, prescription only" in Australia, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Lanreotide TGA approved?
Yes, for its labeled indication. In Australia Lanreotide is classified as "TGA-registered, prescription only". For comparison, the US FDA status is: FDA-approved for acromegaly, for gastroenteropancreatic neuroendocrine tumours to improve progression-free survival, and for carcinoid syndrome.. On the evidence, 1 human study is cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Lanreotide live on its compound profile.
Lanreotide profileThis page is general information about the regulatory status of Lanreotide in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.